Inventor
AMSELEM SHIMON
IL37 patents
⚠️ This page may combine multiple inventors who share the name “AMSELEM SHIMON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AZURA OPHTHALMICS LTD
13 patentsUS10688122B2Jun 23, 2020
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
AZURA OPHTHALMICS LTD18 citations94
US10588915B2Mar 17, 2020
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD19 citations94
US10772899B2Sep 15, 2020
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD8 citations92
US12048707B2Jul 30, 2024
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD3 citations85
US11633410B2Apr 25, 2023
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD6 citations85
US11040062B2Jun 22, 2021
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD8 citations83
US11013749B2May 25, 2021
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD7 citations83
US12011457B2Jun 18, 2024
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD3 citations73
US12447162B2Oct 21, 2025
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations62
US12427158B2Sep 30, 2025
Compositions and methods for the treatment of meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations62
US11484516B2Nov 1, 2022
Agents for increasing meibomian gland lipid secretion
AZURA OPHTHALMICS LTD0 citations62
US12458661B2Nov 4, 2025
Selenium disulfide compositions for use in treating meibomian gland dysfunction
AZURA OPHTHALMICS LTD0 citations61
US12527817B2Jan 20, 2026
Manufacturing of selenium disulfide compositions
AZURA OPHTHALMICS LTD0 citations56
PHARMOS CORP
7 patentsUS5891469AApr 6, 1999
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
PHARMOS CORP220 citations99
US5747061AMay 5, 1998
Suspension of loteprednol etabonate for ear, eye, or nose treatment
PHARMOS CORP149 citations99
US5662932ASep 2, 1997
Solid fat nanoemulsions
PHARMOS CORP255 citations99
US5576016ANov 19, 1996
Solid fat nanoemulsions as drug delivery vehicles
PHARMOS CORP353 citations99
US5993846ANov 30, 1999
Bioadhesive emulsion preparations for enhanced drug delivery
PHARMOS CORP199 citations98
US5961970AOct 5, 1999
Submicron emulsions as vaccine adjuvants
PHARMOS CORP249 citations98
US5514670AMay 7, 1996
Submicron emulsions for delivery of peptides
PHARMOS CORP474 citations98
PAINREFORM LTD
3 patentsUS9668974B2Jun 6, 2017
Depot formulations of a local anesthetic and methods for preparation thereof
PAINREFORM LTD11 citations82
US10206876B2Feb 19, 2019
Depot formulations of a local anesthetic and methods for preparation thereof
PAINREFORM LTD3 citations71
US9849088B2Dec 26, 2017
Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
PAINREFORM LTD2 citations71